共 19 条
- [1] Tawbi HA(2018)Combined nivolumab and ipilimumab in melanoma metastatic to the brain N Engl J Med 379 722-730
- [2] Forsyth PA(2020)Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient J Clin Oncol 38 3733-3784
- [3] Algazi A(2019)Can immunotherapy replace radiotherapy in melanoma brain metastases? J Clin Oncol 37 1030-1031
- [4] Sperduto PW(2019)Adjuvant whole-brain radiation threrapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase iii trial J Clin Oncol 37 3132-3141
- [5] Mesko S(2020)Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients J Immunother Cancer 8 undefined-undefined
- [6] Li J(2019)A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC-X Trial) J Clin Oncol undefined undefined-undefined
- [7] Shinde A(undefined)undefined undefined undefined undefined-undefined
- [8] Li R(undefined)undefined undefined undefined undefined-undefined
- [9] Amini A(undefined)undefined undefined undefined undefined-undefined
- [10] Glaser S(undefined)undefined undefined undefined undefined-undefined